POINT Biopharma Global Inc.

POINT Biopharma Global Inc is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Investing News NetworkYour trusted source for investing success

Could the Silver Price Really Hit $100 per Ounce? (Updated 2024)

How Would a New BRICS Currency Affect the US Dollar? (Updated 2024)

Uranium Stocks: 5 Biggest Companies in 2024

7 Biggest Lithium-mining Companies in 2024

Top 10 Oil-producing Countries (Updated 2024)

Hydrogen Stocks: 9 Biggest Companies in 2024

10 Largest Producers of Gold by Country (Updated 2024)

Top 10 Gold-mining Companies (Updated 2024)

What Was the Highest Price for Gold? (Updated 2024)

Saga Metals Lists on TSX-V

Heritage Mining Announces Partnership with Altitude Capital Consultants Inc. and Non-Brokered Private Placement

Outstanding Drill Results Confirm High Grade Uranium Mineralisation at the Ashburton Project

Pinnacle Silver and Gold Provides Corporate Update and Grants Incentive Stock Options

SAGA Metals Completes IPO with Focus on Uranium Exploration and Rio Tinto Partnership

World Class Copper Potential Increased at Yataga Copper Project – Georgetown, QLD

Saga Metals

Element79 Gold Corp

Forum Energy Metals

Black Swan Graphene

2024 Copper Outlook Report

2024 Gold Outlook Report

2024 Lithium Market Outlook

Silver Price Forecast - What Happened And Where Do We Go From Here?

POINT Biopharma Global Inc.

Pharma Stocks: 5 Biggest Companies in 2024

5 US Longevity and Anti-aging Stocks to Watch in 2024

Interactive Chart